This is one risk that has always concerned me. I've said for many years that PNV should be a long term blue chip Australian owned share. Novosorb applications are effectively endless and we are only now touching the surface of our first almost billion $ market... hence even now I'd vote against a buy out at below $2/share... the medical advantages Novosorb brings are nothing short of extraordinary... let's keep the IP locally owned... if we can...
...hoping for updates on breast reconstruction/hernia/diabetes cure/drug elucidating pellets... perhaps before the AGM??
Gav
- Forums
- ASX - By Stock
- PNV
- Early knockout blow
Early knockout blow, page-7
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.38 |
Change
-0.030(1.24%) |
Mkt cap ! $1.642B |
Open | High | Low | Value | Volume |
$2.42 | $2.44 | $2.36 | $4.288M | 1.798M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 28177 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 26895 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2525 | 2.360 |
6 | 28060 | 2.350 |
2 | 2993 | 2.340 |
2 | 3602 | 2.330 |
1 | 2102 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.400 | 2525 | 1 |
2.410 | 2525 | 1 |
2.420 | 19143 | 4 |
2.430 | 2525 | 1 |
2.440 | 14572 | 4 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online